← SynDRA
TAK-593
SynDRA canonical compound SYN0034184 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | FLT1 | KDR | PDGFRA |
|---|
| Mechanism of action | VEGFR inhibitor |
|---|
All known targets
- KDR
- FLT1
- PDGFRA
- PDGFRB
- FLT4
Mechanisms of action (all sources)
- PDGFRB INHIBITOR
- Platelet-derived growth factor receptor inhibitor
- PDGFRA INHIBITOR
- FLT1 INHIBITOR
- Vascular endothelial growth factor receptor inhibitor
- FLT4 INHIBITOR
- KDR INHIBITOR
- VEGFR inhibitor
- KDR MODULATOR
- PDGFRB MODULATOR
Cross-references
Synonyms
- TAK 593
- UNII-H3I42X8XX7
- H3I42X8XX7
- CHEMBL2180604
- 1H-Pyrazole-5-carboxamide, N-[5-[[2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl]oxy]-2-methylphenyl]-1,3-dimethyl-;1H-Pyrazole-5-carboxamide, N-[5-[[2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl]oxy]-2-methylphenyl]-1,3-dimethyl-
- SCHEMBL2515478
- DZFZXPPHBWCXPQ-UHFFFAOYSA-N
- ZINC95579919
- BDBM50399537
- AKOS030526192
- CS-2403
- DB13093
- NCGC00485933-01
- 1H-Pyrazole-5-carboxamide, N-(5-((2-((cyclopropylcarbonyl)amino)imidazo
- TAK593
- RefChem:187192
- VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593
- orb1307706
- C23H23N7O3
- EX-A5959
- FQB78062
- TAK-593?
- MFCD23160045
- NSC800939
- EBC-219044
- NSC-800939
- NCGC00485933-02
- HY-15506
- MS-28025
- NS00073069
- C13977
- T16975
- BRD-K67262033-001-01-0
Look up TAK-593 in the interactive SynDRA portal →